v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Condensed Consolidated Statements of Operations and Comprehensive Loss        
Grant revenue   $ 118,111   $ 280,574
Operating expenses:        
Research and development $ 2,462,042 1,912,213 $ 4,073,209 4,395,279
General and administrative 1,570,138 1,593,671 3,389,383 3,358,650
Total operating expenses 4,032,180 3,505,884 7,462,592 7,753,929
Loss from operations (4,032,180) (3,387,773) (7,462,592) (7,473,355)
Other income (expense):        
Interest income 358,923 178,027 493,707 382,753
Other income 79,000   79,000  
Foreign currency gain (loss) 2,953 (29,124) 10,664 (80,927)
Total other income 440,876 148,903 583,371 301,826
Net loss (3,591,304) (3,238,870) (6,879,221) (7,171,529)
Other comprehensive income:        
Foreign currency translation 8,083 (1,681) 17,097 (1,038)
Total comprehensive loss $ (3,583,221) $ (3,240,551) $ (6,862,124) $ (7,172,567)
Net loss per share attributable to common stockholders, basic (in dollars per share) $ (0.07) $ (0.53) $ (0.2) $ (1.19)
Net loss per share attributable to common stockholders, diluted (in dollars per share) $ (0.07) $ (0.53) $ (0.2) $ (1.19)
Weighted-average common shares outstanding, basic (in shares) 53,483,504 6,083,329 34,191,653 6,038,845
Weighted-average common shares outstanding, diluted (in shares) 53,483,504 6,083,329 34,191,653 6,038,845